The World Health Organisation (WHO) has revealed that two of four Ebola treatment pills have been found to be more effective and will be the only onesto be prescribed henceforth.
WHO announced this in a trial which began as part of the emergency response in the Democratic Republic of Congo. The trial was tagged the Pamoja Tulinde Maisha study, BBC reports.
The trial was done in collaboration with organisations such as the Congo’s National Institute for Biomedical Research, the ministry of health, the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) the Alliance for International Medical Action among others.
About 681 patients were enrolled in the trial on Friday, August 9, with a total aim of 725 patients to be treated.
According to (NIAID) the pills, REGN-EB3 and mAb114, will from now on be for the treatment of the killer disease.
Follow us on facebook _@Wothappen
twitter_@Wothappen9ja for more stories